The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity
Authors:
- Alberto MorenoAMAlberto Moreno
- Victoria ValeroVVVictoria Valero
- Luis MurilloLMLuis Murillo
- Ana Lucía MoraAMAna Lucía Mora
- Mauricio RojasMRMauricio Rojas
- Claudia RochaCRClaudia Rocha
- Margarita SalcedoMSMargarita Salcedo
- Fanny GuzmanFGFanny Guzman
- Fabiola EspejoFEFabiola Espejo
- Francisco NũnezFNFrancisco Nũnez
- Manuel E. PatarroyoMPManuel E. Patarroyo
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malariaClinical and Experimental Immunology, 1991
- A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malariaNature, 1988
- A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloningNature, 1987
- Induction of protective immunity against experimental infection with malaria using synthetic peptidesNature, 1987
- Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoitesNature, 1987
- Malaria: Immunity, vaccination and immunodiagnosisCellular and Molecular Life Sciences, 1984
- Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum.Journal of Experimental Medicine, 1984
- Malaria — Resurgence, Resistance, and ResearchNew England Journal of Medicine, 1983
- Malaria — Resurgence, Resistance, and ResearchNew England Journal of Medicine, 1983
- Direct microsequence analysis of polypeptides using an improved sequenator, a nonprotein carrier (Polybrene), and high pressure liquid chromatographyBiochemistry, 1978